Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Selegiline »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Selection Bias < Selegiline < Selenium  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 45.
[20-40] [0 - 20][0 - 45][40-44][40-60]
Ident.Authors (with country if any)Title
004728 (1995) S. Przedborski [États-Unis] ; V. Jackson-Lewis ; S. FahnAntiparkinsonian therapies and brain mitochondrial complex I activity.
004735 (1995) T L Davis [États-Unis] ; M. Roznoski ; R S BurnsEffects of tolcapone in Parkinson's patients taking L-dihydroxyphenylalanine/carbidopa and selegiline.
004736 (1995) J C Garcia-Monco ; A. Padierna ; M. Gomez BeldarrainSelegiline, fluoxetine, and depression in Parkinson's disease.
004895 (1994) T. Klockgether [Allemagne] ; J. DichgansVisual control of arm movement in Parkinson's disease.
004945 (1993) C W Olanow [États-Unis]A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease.
004946 (1993) K T FinneganNeurotoxins and monoamine oxidase inhibition: new aspects.
004947 (1993) W G Tatton [Canada]Selegiline can mediate neuronal rescue rather than neuronal protection.
004948 (1993) J O Rinne [Finlande]Nigral degeneration in Parkinson's disease.
004949 (1993) H. Allain [France] ; P. Pollak ; H C NeukirchSymptomatic effect of selegiline in de novo Parkinsonian patients. The French Selegiline Multicenter Trial.
004950 (1993) V V Myllyl [Finlande] ; K A Sotaniemi ; J A Vuorinen ; E H HeinonenSelegiline in de novo parkinsonian patients: the Finnish study.
004951 (1993) M B Youdim [Israël] ; P. RiedererThe relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in Parkinson's disease.
004955 (1993) B. Pardo [Espagne] ; M A Mena ; S. Fahn ; J. García De YébenesAscorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line.
004A44 (1995) C. Stewart [États-Unis] ; L. Winfield ; A. Hunt ; S B Bressman ; S. Fahn ; A. Blitzer ; M F BrinSpeech dysfunction in early Parkinson's disease.
004A45 (1995) J E Ahlskog [États-Unis] ; R J Uitti ; P A Low ; G M Tyce ; K K Nickander ; R C Petersen ; E. KokmenNo evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
004C73 (1997) J P Larsen [Norvège] ; J. BoasThe effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: an interim analysis of a Norwegian--Danish 5-year study. Norwegian-Danish Study Group.
004C74 (1997) P. Lewitt [États-Unis] ; D. Oakes ; L. CuiThe need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
004C97 (1997) N. Andreu [France] ; C. Damase-Michel ; J M Senard ; O. Rascol ; J L MontastrucA dose-ranging study of selegiline in patients with Parkinson's disease: effect of platelet monoamine oxidase activity.
004D37 (1997) J. Lyytinen [Finlande] ; S. Kaakkola ; S. Ahtila ; P. Tuomainen ; H. Ter V InenSimultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease.
004D88 (1997) R A Hauser [États-Unis] ; T A ZesiewiczSertraline for the treatment of depression in Parkinson's disease.
004E24 (1997) I. Soykan [États-Unis] ; I. Sarosiek ; J. Shifflett ; G F Wooten ; R W MccallumEffect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
004E65 (1998) P. Hagell [Suède] ; P. Odin ; E. VingePregnancy in Parkinson's disease: a review of the literature and a case report.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Selegiline" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Selegiline" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Selegiline
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024